Pelacarsen and Ziltivekimab successfully lowered key biological markers, but neither reduced heart attacks, strokes, or cardiovascular deaths in clinical trials
Study finds that adding just 11 minutes of sleep nightly, along with improvements in diet and physical activity, may significantly reduce the risk of heart attack and other cardiovascular events.